'New drug' presentation slideshows

Mining Frequent Patterns and Association Rules

1.24k views • 93 slides

3D Structures of Biological Macromolecules Part 3: Drug Research and Design

963 views • 76 slides

816 views • 67 slides

Using Genomics in Clinical Trial Design

Using Genomics in Clinical Trial Design. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://linus.nci.nih.gov. BRB Website http://linus.nci.nih.gov/brb. Powerpoint presentations and audio files Reprints & Technical Reports BRB-ArrayTools software

1.01k views • 62 slides

Fraud & Misconduct at Investigator Sites

Fraud & Misconduct at Investigator Sites. Paul Below Medical Affairs - 3M Pharmaceuticals Presented to the Great Plains Chapter ACRP March 27, 2003. Disclaimer / Disclosure.

956 views • 58 slides

Design & Analysis of Phase III Trials for Predictive Oncology

Design & Analysis of Phase III Trials for Predictive Oncology. Richard Simon Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov.

602 views • 44 slides

Joseph A. DiMasi, Ph.D. Tufts Center for the Study of Drug Development Tufts University The New England Drug Metabolism

The Economics of New Drug Development: Costs, Risks, and Returns. Joseph A. DiMasi, Ph.D. Tufts Center for the Study of Drug Development Tufts University The New England Drug Metabolism Group Spring Meeting Cambridge, MA, March 12, 2008. Agenda. Drug development times

911 views • 43 slides

STANDARD COURSE IN CLINICAL TRIAL

STANDARD COURSE IN CLINICAL TRIAL. PIENGTHONG NARAKORN May 23, 2008. OUTLINE: March 24, 2008. From R&D product to licensing Study design & research methodology for clinical trials Proposal development Grant hunting, fund management, research administration & human resource management

719 views • 35 slides

Myers PSYCHOLOGY

Myers PSYCHOLOGY . Module 4 Neural and Hormonal Systems. Neural Communication. Biological Psychology branch of psychology concerned with the links between biology and behavior

757 views • 34 slides

Complying with FDA/OIG Rules

Complying with FDA/OIG Rules. Wayne L. Pines August 24, 2006. Wayne Pines. Consultant to pharma/devices industries on advertising/ promotion issues, crisis control Former Associate Commissioner for Public Affairs, FDA Author/editor, FDA Advertising and Promotion Manual, 10 others books .

504 views • 32 slides

Databases or Registries? Points to Consider

Databases or Registries? Points to Consider. Mary Lou Skovron, DrPH Group Director, Global Epidemiology Bristol-Myers Squibb FDA/Industry Statistics Workshop September 29, 2006. Overview. Claims databases Types Advantages Limitations Registries Types Advantages Limitations Examples

513 views • 30 slides

Track E: Rapporteur Summary Pierre Barker

Track E: Rapporteur Summary Pierre Barker. Track E: Rapporteur Summary. Role of health systems in providing high quality care to all who need it The financing of health systems that provide HIV care Operations Research on quality of care, universal coverage, and financing. Track E.

457 views • 28 slides

Correlation and the logic of significance testing

Correlation and the logic of significance testing. Practice.

822 views • 27 slides

Detecting Differentially Expressed Genes

Detecting Differentially Expressed Genes. Pengyu Hong 09/13/2005. Background (Microarray). Extract RNA. Cells. Background. Extract RNA. Cells. Background. Extract RNA. Cells. Background. Extract RNA. Cells. Background. Extract RNA. Cells. 10 4 + genes. Background. Extract RNA.

449 views • 27 slides

Korean Biotech Industry in 2004 - Past, Now, & Future -

Korean Biotech Industry in 2004 - Past, Now, & Future -. March 2004. Notice. These slides are only for the presentation at the 8 th Nomura Bio Conference Asia Pacific 2004, written by Byong Seung Cho, an investment associate at Korea Technology Investment Corp.

312 views • 23 slides

Drug design and testing,

Drug design and testing,. Drug Names. Chemical name- describes its molecular structure and distinguishes it from other drugs. Generic name- is determined by the pharmaceutical company along with the a special organization known as the U.S. Adopted names Council.

439 views • 22 slides

Labor Forecasting at Eli Lilly and Company

Labor Forecasting at Eli Lilly and Company. Kevin Ross Assistant Professor Information Systems and Technology Management UCSC. Outline. About Eli Lilly and Company The Tippecanoe Manufacturing Facility Decision Science Team Forecasting Challenge Solution and Recommendations

442 views • 22 slides

408 views • 22 slides

Premarket Testing and Validation

Premarket Testing and Validation. "The greatest lesson in life is to know that even fools are right sometimes" Sir Winston Churchill . Standard Tests. Cycle testing [on/off, etc.] Typical use testing [Elec. & Mech. Test, typical, aim for MTBF values]

267 views • 10 slides

The Cost of Developing a New Drug Has Greatly Increased

The Cost of Developing a New Drug Has Greatly Increased. Cost to Develop One New Drug 1. Billions (Constant Dollars, Year 2000).

88 views • 1 slides